Avapro

DRUG3 trials

Sponsors

Roxane Laboratories, Baylor Research Institute

Conditions

Chronic Kidney DiseaseHypertensionType 2 Diabetes

Phase 4

Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)

Not yet recruitingNCT07547878

Baylor Research InstituteChronic Kidney Disease, Type 2 Diabetes

Start: 2026-04-30End: 2029-03-31Target: 64Updated: 2026-05-08

Unknown Phase

Crossover Bioequivalence Study of Irbesartan 300 mg Tablets Under Fed Conditions

CompletedNCT01712100

Roxane LaboratoriesHypertension

Start: 2007-08-31End: 2007-08-31Updated: 2018-01-23

Crossover Bioequivalence Study of Irbesartan 300 mg Tablets Under Fasted Conditions

CompletedNCT01712113

Roxane LaboratoriesHypertension

Start: 2007-08-31End: 2007-08-31Updated: 2018-01-23